Navigation Links
China Biopharma, Inc. Announces New Plan of Operation
Date:11/20/2007

HANGZHOU, China, Nov. 20 /PRNewswire-FirstCall/ -- China Biopharma, Inc. (OTC Bulletin Board: CBPC) today announced its new plan of operation to take closer control and to better improve its current operation results. The company also plans to move away from the increasingly competitive and low margin vaccine business, and to enter new specialty pharmaceutical products.

"We plan to take more control on the available cash in out subsidiaries and move into higher market potential and higher margin specialty pharmaceutical products," says Peter Wang, CEO and Chairman of Board. "And we are negotiating with a few global vaccine manufacturers now for carrying their higher margin products, in order to avoid direct competitions with other manufacturers."

Recent changes in vaccine sectors have resulted in more vaccine manufacturers entering into low margin vaccine business such as flu vaccine, thus creating severe competition among, and squeezed profit margin of, vaccine distributors such as China Biopharma. Besides moving away from the low margin vaccine business, the company also starts to enter specialty pharmaceutical products such as the recently released anti-viral products.

China Biopharma has most of its operation in China. Working to take direct control on subsidiaries' operation and financial management, the company plans to increase its shareholding in China Zhejiang Tianyuan Biotech Co., Ltd., and eventually to have 100% control and ownership in this joint venture. With internally available resources, there would be no need to raise additional capital to complete the transactions. This is expected to improve current performance and increase operation stability.

"This new direction is expected to preserve available cash position and give us more operation flexibility," says Chunhui Shu, the new interim Chief Financial Officer. "In view of improvement and progress on our current operation results, we have made this plan to take more e
'/>"/>

SOURCE China Biopharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...portant is the biotech industry to the economy of ...Or Boston. , ,Better yet, look at the numbers. , ...omics for the Santa Monica-based Milken Institute...t the Biotechnology Industry Organization,s annual...ted to know where that city stood in comparison to...
...i-spam solutions , ,Green Bay, Wis. MailFoundry...olutions, announced two new high availability Mail... and 8100. They are priced at $6,999 and $12,999, ...ts or restrictions. , ,All MailFoundry anti-spam a...scanning engine, a human intelligence driven techn...
...requency identification technology is often touted...in the health care world, the technology is bringi...and security. , ,"Everybody wants to focus on the ...tions in health care a lot of applications that s...n analyst with Robert W. Baird and Co. in Milwau...
...quency identification technology may seem simple: ...ion-embedded chip, with an antenna enabling the tr...sics related to the antenna is where things can ge...allenges is a key to bringing the price of transpo...t level - a level that market analysts say is nece...
Other Biology Technology:Better collaboration urged to further Wisconsin biotech 2Tech Digest: MailFoundry; API Software 2RFID can be a matter of life and death in the medical world 2RFID can be a matter of life and death in the medical world 3RFID can be a matter of life and death in the medical world 4RFID can be a matter of life and death in the medical world 5Making RFID mainstream 2Making RFID mainstream 3Making RFID mainstream 4
(Date:7/24/2008)...tate University College of Medicine, Hershey, Penn...uimod, a clinically important immune response modi... is dependent on the Opioid Growth Factor (OGF)-OG...very, reported in the August 08 issue of Experime...into a widely used drug that may lead to developme...
(Date:7/24/2008)... talk, they might tell potential suitors, "I like ...come slither look. But worms send their valentines...al code researchers are now cracking, according to...nal Nature . , Scientists from the University ...titute of Technology and the U.S. Department of Ag...
(Date:7/24/2008)...uced carbon storage in western U.S. forests , A...entury has caused a widespread increase in fire-in...stems growing on trees within western U.S. forests...re thought to account for much of North America,s ...ound biomass, Fellows and Goulden compare Californ...
(Date:7/23/2008)...together internationally renowned scientists from ...apan, Australia and India to address ancient micr...e are bringing together the world,s best scientist...izer J. William Schopf, founder and director of th...cs, Center for the Study of Evolution and the Orig...
Breaking Biology News(10 mins):Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3AGU journal highlights -- July 23, 2008 2AGU journal highlights -- July 23, 2008 3AGU journal highlights -- July 23, 2008 4AGU journal highlights -- July 23, 2008 5AGU journal highlights -- July 23, 2008 6AGU journal highlights -- July 23, 2008 7AGU journal highlights -- July 23, 2008 8UCLA 'world summit' to explore ancient life on Earth, and beyond 2King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 1King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 2King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 3King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 4King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 5King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 6Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 1Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 2Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 3Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 4Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 5Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 6Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 7Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 8Amylin Pharmaceuticals to Webcast Conference Call 5055 1Amylin Pharmaceuticals to Webcast Conference Call 5055 2Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman 26 Renshaw Healthcare Conference 1603 1Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman 26 Renshaw Healthcare Conference 1603 2
...ncing of human chromosome 17 and mouse chromosome ...e genome of higher mammals, said a Baylor College ...fort reported in today,s issue of the journal Natu...ouse chromosome has been completely sequenced and ...d professor in the BCM department of molecular and...
...ave cracked the site and the stages of development...The researchers found that natural killer (NK) cel...cancer and infections, mature from progenitor stem...at this happens in secondary lymphoid tissue such ...ade decades ago in animals and humans showed that ...
... Uppsala University, Sweden has shown in a new stu...the size of the spot on a male collared flycatcher...ystem combats viruses such as avian influenza. The...rching for a mate. , Evolutionary biologists have...ecies differ in appearance and why the choice of a...
...healing process for common ear infections will be ...s Ear and Hearing Institute (LEHI). , The research...themselves (and why some do not heal at all) by id...d-healing process of an infected human ear drum. ,...st half of the world,s population suffers from ,ch...
Other Biology News:Mouse to man: The story of chromosomes 2Front-line immune cells mature in four stages, study shows 2Attractive birds more immune against bird flu 2World first research to speed up cure for ear infections 2
The epitope recognized by A300-183A maps to the C-terminus of isoform 5 of human quaking homolog according to entry AAH19917.1 (GeneID 9444). The epitope is not found in isoforms 1, 2, 3, 4, 6, 7 or
... ml Dynabeads Epoxy (4.5 m). Hydrophobic naked be...deal for coupling of antibodies for cell applicati...ial coupling with covalent binding of primary amin...ring within 16-20 hours. Coupling reactions can be...
Flotillin-2 (ESA) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 29, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details.
St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles
Biology Products: